Viewing Study NCT00250211



Ignite Creation Date: 2024-05-05 @ 12:08 PM
Last Modification Date: 2024-10-26 @ 9:20 AM
Study NCT ID: NCT00250211
Status: COMPLETED
Last Update Posted: 2016-02-24
First Post: 2005-11-04

Brief Title: Magnetic Resonance Spectroscopic Imaging MRS and Tumor Perfusion of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide
Sponsor: AHS Cancer Control Alberta
Organization: AHS Cancer Control Alberta

Study Overview

Official Title: Multimodality Functional Imaging MRS and Tumor Perfusion Predicts Tumor Migration Invasiveness and Patterns of Failure of Human Glioblastoma Treated With Concurrent Radiation Therapy and Temozolomide
Status: COMPLETED
Status Verified Date: 2011-10
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to learn whether 3 tesla 3T MRI functional imaging will map a tumor more accurately allowing a more targeted delivery of radiation The investigators hope to learn whether tomotherapy will be able to deliver higher radiation doses safely to the tumor while sparing the surrounding normal tissue
Detailed Description: None

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None